-
Details
-
Written by Mohammad Bagher Rahmati, Keramat Allah Jahanshahi, Zahra Jahangiri, Hamidreza Mahboobi, Tahereh Khorgoei
-
Parent Category: Year 2012, Volume 4
-
Category: Year 2012, Volume 4, Issue 1, January-April 2012
-
Hits: 58112
Background: Kawasaki Disease (KD) is a self-limiting vasculitis and is the main cause of acquired cardiac disease in childhood in developed countries. Early diagnosis and treatment of KD is necessary for prevention of cardiac complications in adolescence. The aim of the present study is to assess clinical aspects and laboratory tests in KD in Iran.
Methods: The study, undertaken in 2009, included all patients admitted to Kudakan hospital in Bandarabbas with a diagnosis of KD during 1997 to 2008. Forty-two children were included in this study. Seven patients were excluded because of incomplete records. All eligible patients’ records were reviewed and data including age, sex, clinical findings, and laboratory test results were summarized in a structured checklist. Data were analyzed using SPSS 13.0 for Windows (SPSS Inc., Chicago, Illinois, USA) software.
Results: Among the 35 patients studied, seven (20%) were female, and 28 (80%) were male. Mean age of the patients was 3.35±2.4. Fever was seen in 35(100%) patients, noninfectious bilateral conjunctivitis in 16(45.71%), noninfectious unilateral conjunctivitis in two (5.7%), lip color change in 18(51.4%), involvement of oropharynx in 19(54.3%), strawberry tongue in 11(31.4%), maculopapular rash in 18(51.4%), and erythmatous skin in six (17.1%). Ten patients had an erythrocyte sediment rate (ESR) less than 30.
Conclusion: Prevalence of clinical findings in Iran is variable among different areas. Thus KD should be considered in all children with fever lasting five days or longer to prevent cardiac complications in future..
Key words: Kawasaki Disease; Clinical Aspects; Laboratory Tests
Nike Air MaxNike
The most recent editorial (June 2021)
Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?
An editorial by Dr. Mehrdad Jalalian
Read more.
The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.
To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here
Our previous editorial (June 2020)
Lessons from COVID-19 pandemic and the Morocco’s success story.
An editorial by Dr. Benksim Abdelhafid (Morocco)
Read more.
The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.
The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:
TDR Clinical Research and Development Fellowships
Call for applications
Deadline for submission: 7 March 2019, 16:00 (GMT)
TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:
Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019
Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).
About the Instructor
Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more:
